AWS vs Azure for Life Sciences: A Regulated Industry Comparison

Why Platform Choice Matters in Regulated Environments

Choosing between AWS and Microsoft Azure is one of the most consequential technology decisions a life sciences IT leader will make. Both platforms are mature, enterprise-grade, and capable of supporting GxP-regulated workloads — but they differ significantly in compliance documentation maturity, life sciences partner ecosystems, validation tooling, and cost structures.

This comparison focuses specifically on the regulated life sciences context. We cover the dimensions that matter to QA directors, IT leaders, CTOs, and compliance managers in pharmaceutical, biotech, and medical device organisations.

Compliance Documentation and GxP Support

AWS

AWS has invested heavily in life sciences-specific compliance documentation. Key resources include the AWS GxP Guidelines whitepaper (2023), AWS Audit Manager with pre-built GxP control frameworks, and the AWS Compliance Centre with mapped documentation for Annex 11, 21 CFR Part 11, and HIPAA. AWS Artifact provides SOC 1, SOC 2, ISO 27001, and PCI DSS reports on demand. AWS has a dedicated Life Sciences team with published reference architectures for GMP, GCP, and HIPAA environments.

Azure

Microsoft Azure also provides strong compliance documentation, particularly for pharmaceutical customers already invested in the Microsoft ecosystem. Azure has published a Pharmaceutical and Life Sciences compliance guide and offers Azure Compliance Manager (now Microsoft Purview Compliance Manager) with assessment templates. Azure's compliance documentation is generally strong for Microsoft-adjacent frameworks (Azure AD, Office 365) but the GxP-specific tooling is less purpose-built than AWS's equivalent.

Verdict

AWS has a more mature, purpose-built set of GxP documentation and life sciences compliance tooling. Azure's strength is its integration with the broader Microsoft ecosystem (Office 365, SharePoint, Teams) which can simplify the overall compliance posture for organisations already on Microsoft infrastructure.

Life Sciences Partner Ecosystem

AWS

AWS has the largest life sciences partner ecosystem globally. The AWS Partner Network (APN) includes hundreds of ISVs offering validated LIMS platforms, ELN solutions, clinical data management systems, and GxP-validated infrastructure. Major LIMS vendors (LabWare, STARLIMS), ELN providers (Benchling, LabArchives), and CDM platforms (Medidata, Veeva) have validated AWS offerings. AWS re:Invent and AWS Life Sciences events provide dedicated forums for the sector.

Azure

Azure has a strong partner ecosystem with particular depth in clinical operations software (many major CROs and sponsors use Azure-hosted EDC systems), Microsoft Dynamics 365 for life sciences CRM, and LIMS providers including LabVantage. Microsoft's relationship with SAP, Oracle, and major ERP vendors means Azure is well-represented in manufacturing ERP contexts.

Verdict

AWS has a larger overall life sciences ISV ecosystem. Azure has advantages in clinical operations and Microsoft-integrated workflows. Both have sufficient depth for most enterprise life sciences requirements.

Key Services Comparison

The following table compares key services relevant to regulated life sciences workloads:

Cost Structures

AWS and Azure use broadly similar pricing models — on-demand, reserved, and spot/preemptible pricing — but differ in discount structures and commitment terms. AWS Reserved Instances offer up to 72% savings for 1 or 3-year commitments. AWS Savings Plans provide more flexible commitment-based discounts across EC2, Lambda, and Fargate. Azure Reserved Virtual Machine Instances offer comparable savings (up to 72%) but Azure Hybrid Benefit — which allows customers to apply existing Windows Server and SQL Server licences to Azure VMs — is a meaningful cost advantage for Microsoft-licensed organisations.

For life sciences organisations with significant Microsoft licensing (Windows Server, SQL Server, Office 365), Azure's Hybrid Benefit can substantially reduce total cost of ownership for those workloads. For Linux-based, cloud-native, or Python/R scientific computing workloads, AWS typically offers comparable or better pricing.

Data Residency and UK Sovereignty

Both platforms have UK data centre regions: AWS has eu-west-2 (London) and Azure has UK South and UK West. Both support data residency guarantees keeping regulated data within UK borders. For NHS-connected organisations or those subject to DSPT requirements, Azure is more commonly used due to Microsoft's established NHS framework agreements.

Making the Decision

AWS is typically the better choice for: organisations without existing Microsoft infrastructure commitments; those with heavy scientific computing, genomics, or ML workloads; and those prioritising the broadest life sciences ISV ecosystem. Azure is typically the better choice for: organisations deeply invested in Microsoft 365, SharePoint, or Dynamics; those with significant Windows Server or SQL Server licensing; and clinical operations environments using Azure-native EDC or eTMF platforms. A multi-cloud approach — AWS for primary workloads with Azure for Microsoft-integrated workflows — is increasingly common among large pharmaceutical organisations.